These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19672874)

  • 1. Integrative approach for prioritizing cancer genes in sporadic colon cancer.
    Reid JF; Gariboldi M; Sokolova V; Capobianco P; Lampis A; Perrone F; Signoroni S; Costa A; Leo E; Pilotti S; Pierotti MA
    Genes Chromosomes Cancer; 2009 Nov; 48(11):953-62. PubMed ID: 19672874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic analysis in APC, KRAS, and TP53 in patients with stomach and colon cancer.
    Palacio-Rúa KA; Isaza-Jiménez LF; Ahumada-Rodríguez E; Muñetón-Peña CM
    Rev Gastroenterol Mex; 2014; 79(2):79-89. PubMed ID: 24861525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copy number of the Adenomatous Polyposis Coli gene is not always neutral in sporadic colorectal cancers with loss of heterozygosity for the gene.
    Zauber P; Marotta S; Sabbath-Solitare M
    BMC Cancer; 2016 Mar; 16():213. PubMed ID: 26970738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in K-ras, APC and p53-multiple genetic pathway in colorectal cancer among Indians.
    Malhotra P; Anwar M; Nanda N; Kochhar R; Wig JD; Vaiphei K; Mahmood S
    Tumour Biol; 2013 Jun; 34(3):1901-11. PubMed ID: 23526092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The presence of telomere fusion in sporadic colon cancer independently of disease stage, TP53/KRAS mutation status, mean telomere length, and telomerase activity.
    Tanaka H; Beam MJ; Caruana K
    Neoplasia; 2014 Oct; 16(10):814-23. PubMed ID: 25379018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonality, founder mutations, and field cancerization in human ulcerative colitis-associated neoplasia.
    Leedham SJ; Graham TA; Oukrif D; McDonald SA; Rodriguez-Justo M; Harrison RF; Shepherd NA; Novelli MR; Jankowski JA; Wright NA
    Gastroenterology; 2009 Feb; 136(2):542-50.e6. PubMed ID: 19103203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A gene marker panel covering the Wnt and the Ras-Raf-MEK-MAPK signalling pathways allows to detect gene mutations in 80% of early (UICC I) colon cancer stages in humans.
    Scholtka B; Schneider M; Melcher R; Katzenberger T; Friedrich D; Berghof-Jäger K; Scheppach W; Steinberg P
    Cancer Epidemiol; 2009 Aug; 33(2):123-9. PubMed ID: 19679059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KRAS mutations in traditional serrated adenomas from Korea herald an aggressive phenotype.
    Kim KM; Lee EJ; Kim YH; Chang DK; Odze RD
    Am J Surg Pathol; 2010 May; 34(5):667-75. PubMed ID: 20305537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsatellite instability-low colorectal cancer acquires a KRAS mutation during the progression from Dukes' A to Dukes' B.
    Asaka S; Arai Y; Nishimura Y; Yamaguchi K; Ishikubo T; Yatsuoka T; Tanaka Y; Akagi K
    Carcinogenesis; 2009 Mar; 30(3):494-9. PubMed ID: 19147861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copy number variations in DCC/18q and ERBB2/17q are associated with disease-free survival in microsatellite stable colon cancer.
    Sefrioui D; Vermeulin T; Blanchard F; Chapusot C; Beaussire L; Armengol-Debeir L; Sesboué R; Gangloff A; Hebbar M; Copin MC; Houivet E; Schwarz L; Clatot F; Tuech JJ; Bénichou J; Martin L; Bouvier AM; Sabourin JC; Sarafan-Vasseur N; Frébourg T; Lepage C; Michel P; Di Fiore F
    Int J Cancer; 2017 Apr; 140(7):1653-1661. PubMed ID: 28006840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients.
    van den Broek E; Krijgsman O; Sie D; Tijssen M; Mongera S; van de Wiel MA; Belt EJ; den Uil SH; Bril H; Stockmann HB; Ylstra B; Carvalho B; Meijer GA; Fijneman RJ
    Oncotarget; 2016 Nov; 7(45):73876-73887. PubMed ID: 27729614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue biomarker development in a multicentre trial context: a feasibility study on the PETACC3 stage II and III colon cancer adjuvant treatment trial.
    Bosman FT; Yan P; Tejpar S; Fiocca R; Van Cutsem E; Kennedy RD; Dietrich D; Roth A
    Clin Cancer Res; 2009 Sep; 15(17):5528-33. PubMed ID: 19690194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.
    Abubaker J; Bavi P; Al-Haqawi W; Sultana M; Al-Harbi S; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
    J Pathol; 2009 Dec; 219(4):435-45. PubMed ID: 19824059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic KRAS is not necessary for Wnt signalling activation in APC-associated FAP adenomas.
    Obrador-Hevia A; Chin SF; González S; Rees J; Vilardell F; Greenson JK; Cordero D; Moreno V; Caldas C; Capellá G
    J Pathol; 2010 May; 221(1):57-67. PubMed ID: 20196079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers.
    Barault L; Veyrie N; Jooste V; Lecorre D; Chapusot C; Ferraz JM; Lièvre A; Cortet M; Bouvier AM; Rat P; Roignot P; Faivre J; Laurent-Puig P; Piard F
    Int J Cancer; 2008 May; 122(10):2255-9. PubMed ID: 18224685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse model of proximal colon-specific tumorigenesis driven by microsatellite instability-induced Cre-mediated inactivation of Apc and activation of Kras.
    Kawaguchi Y; Hinoi T; Saito Y; Adachi T; Miguchi M; Niitsu H; Sasada T; Shimomura M; Egi H; Oka S; Tanaka S; Chayama K; Sentani K; Oue N; Yasui W; Ohdan H
    J Gastroenterol; 2016 May; 51(5):447-57. PubMed ID: 26361962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different genetic features associated with colon and rectal carcinogenesis.
    Frattini M; Balestra D; Suardi S; Oggionni M; Alberici P; Radice P; Costa A; Daidone MG; Leo E; Pilotti S; Bertario L; Pierotti MA
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4015-21. PubMed ID: 15217933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer with and without microsatellite instability involves different genes.
    Salahshor S; Kressner U; Pâhlman L; Glimelius B; Lindmark G; Lindblom A
    Genes Chromosomes Cancer; 1999 Nov; 26(3):247-52. PubMed ID: 10502323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comet fluorescence in situ hybridization analysis for oxidative stress-induced DNA damage in colon cancer relevant genes.
    Glei M; Schaeferhenrich A; Claussen U; Kuechler A; Liehr T; Weise A; Marian B; Sendt W; Pool-Zobel BL
    Toxicol Sci; 2007 Apr; 96(2):279-84. PubMed ID: 17192441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.